5-Amino-1MQ
Also known as: 5-amino 1MQ, 5-Amino-1-methylquinolinium
5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that blocks the enzyme responsible for converting nicotinamide to N-methylnicotinamide, potentially enhancing cellular energy production and promoting fat loss.
5-Amino-1MQ is a 159.21 g/mol research peptide. 5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that blocks the enzyme responsible for converting nicotinamide to N-methylnicotinamide, potentially enhancing cellular energy production and promoting fat loss.
Also called: 5-amino 1MQ, 5-Amino-1-methylquinolinium
159.21 g/mol
Molecular Weight
Daltons
0
Strong Evidence
benefits
4
Studies Cited
peer-reviewed
50-100
Typical Dose
mg
Overview
5-Amino-1MQ targets NNMT, an enzyme that uses up NAD+ (nicotinamide adenine dinucleotide) by methylating nicotinamide. When NNMT activity increases, cellular NAD+ levels drop, which can slow metabolism and reduce energy production. By inhibiting this enzyme, 5-Amino-1MQ may help preserve NAD+ levels, supporting better mitochondrial function and metabolic health. Research suggests this mechanism could lead to increased energy expenditure, improved insulin sensitivity, and enhanced fat oxidation. The compound has gained attention for its potential to address metabolic dysfunction without directly affecting appetite, instead working through cellular energy pathways.
Key Takeaways: 5-Amino-1MQ
- Research doses typically range from 50 to 100 mg via oral
- 0 benefits with strong evidence, 0 moderate, 5 preliminary
- Half-life: 2-4 hours
- 4 cited research studies in this guide
Mechanism of Action
5-Amino-1MQ selectively inhibits NNMT enzyme activity, preventing the methylation of nicotinamide and preserving cellular NAD+ levels. Higher NAD+ concentrations support enhanced mitochondrial oxidative phosphorylation, increased SIRT1 activity, and improved cellular energy metabolism. This mechanism may activate AMPK pathways and promote fatty acid oxidation while reducing lipogenesis.
Research Benefits
5-Amino-1MQ at a Glance
5-Amino-1MQ selectively inhibits NNMT enzyme activity, preventing the methylation of nicotinamide and preserving cellular NAD+ levels.
Enhanced Fat Oxidation
PreliminaryNNMT inhibition preserves NAD+ levels, which support mitochondrial fatty acid oxidation and may increase metabolic rate by 10-15% based on preclinical studies.
Improved Insulin Sensitivity
PreliminaryHigher NAD+ availability activates SIRT1 and AMPK pathways that enhance glucose uptake and insulin signaling in muscle and adipose tissue.
Increased Energy Expenditure
PreliminaryEnhanced mitochondrial function from preserved NAD+ levels may boost thermogenesis and overall daily energy expenditure without stimulant effects.
Body Composition Improvement
PreliminaryResearch indicates NNMT inhibition can reduce adipose tissue accumulation while preserving lean muscle mass during weight loss phases.
Metabolic Flexibility Enhancement
PreliminaryNAD+ preservation supports the cellular machinery needed to efficiently switch between glucose and fat as fuel sources based on availability.
Anti-Aging Cellular Effects
AnecdotalHigher NAD+ levels activate sirtuins and DNA repair mechanisms that may slow cellular aging processes and improve healthspan markers.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| Metabolic enhancement | 50–100 mg | oral |
| Fat loss support | 75–150 mg | oral |
| NAD+ optimization | 25–75 mg | oral |
Frequency
Once daily, preferably in the morning
Timing
Take on empty stomach 30-60 minutes before first meal for optimal absorption
Cycle Length
8-12 weeks followed by 2-4 week break
Research Notes
- 1Start with lowest effective dose to assess tolerance
- 2May be taken with other NAD+ precursors like NMN or NR
- 3Effects typically noticed within 1-2 weeks of consistent use
- 4Cycling recommended to prevent potential tolerance development
Reconstitution Guide
Standard Reconstitution
Vial Size
0 mg
Bacteriostatic Water
0 mL
Concentration
NaN mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
5-Amino-1MQ vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 0 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at Room temperature in dry location. 2-3 years when stored properly.
Storage Temperature
Room temperature in dry location
Shelf Life
2-3 years when stored properly
Important Notes
- •Usually supplied as oral capsules or powder
- •Store away from heat, light, and moisture
- •No reconstitution required for oral forms
5-Amino-1MQ Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
5-Amino-1MQ Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Mild nausea or stomach upset (especially when taken without food)
- !Headaches during initial adaptation period
- !Sleep disturbances if taken too late in the day
- !Potential interaction with methylation processes
- !Possible changes in energy levels during adjustment phase
- !Rare reports of skin flushing or warmth sensation
- !Digestive discomfort in sensitive individuals
- !Potential effects on existing metabolic medications
Potential Interactions
- ⚡May enhance effects of diabetes medications - monitor blood glucose
- ⚡Could interact with NAD+ precursor supplements - adjust timing
- ⚡May affect methylation-dependent medications
- ⚡Potential interaction with stimulant compounds
- ⚡Could influence effectiveness of certain nootropics
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
NNMT inhibition improves hepatic insulin sensitivity and reduces obesity
Study demonstrated that NNMT inhibition in animal models led to improved glucose tolerance, reduced body weight, and enhanced insulin sensitivity through NAD+ preservation.
Nicotinamide N-methyltransferase and metabolic health
Research identified NNMT as a key regulator of cellular energy metabolism and demonstrated that its inhibition could influence metabolic phenotypes.
NNMT expression correlates with obesity and metabolic dysfunction
Clinical study found elevated NNMT expression in obese individuals correlated with decreased NAD+ levels and impaired metabolic markers.
Small molecule NNMT inhibitors and their metabolic effects
Research evaluated various NNMT inhibitor compounds including quinolinium derivatives and their potential for treating metabolic disorders.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Most researchers report noticing metabolic changes within 1-2 weeks of consistent dosing. Energy improvements may be felt sooner, while body composition changes typically require 4-6 weeks to become apparent.
Many researchers combine it with NAD+ precursors like NMN or NR, but start with lower doses of each to assess tolerance. The combination may provide synergistic benefits for cellular energy.
Unlike stimulant-based fat burners, 5-Amino-1MQ works by preserving NAD+ levels and enhancing cellular energy production rather than increasing heart rate or suppressing appetite.
Research protocols typically include 2-4 week breaks after 8-12 weeks of use to prevent potential tolerance and allow natural enzyme regulation to reset.
Long-term safety data is limited. Current research focuses on shorter protocols with breaks. Monitor metabolic markers and consider regular blood work during extended research periods.
Morning dosing on an empty stomach appears optimal for absorption and to avoid potential sleep interference. Take 30-60 minutes before your first meal.
Research suggests it may enhance metabolic rate and fat oxidation, but combining with appropriate nutrition and exercise protocols typically produces better results.
Consider tracking glucose, insulin, lipid panels, and liver function markers. Some researchers also monitor NAD+ levels if testing is available.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.